Adapthealth Corp
NASDAQ:AHCO
Adapthealth Corp
NASDAQ:AHCO
Price:
9.72
USD
-0.31%
Market Cap:
$1.3B
Relative Value
The Relative Value of one
AHCO
stock under the Base Case scenario is
25.4
USD.
Compared to the current market price of 9.72 USD,
Adapthealth Corp
is
Undervalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AHCO
Relative Value
Base Case
25.4
USD
Undervaluation 62%
Multiples Across Competitors
AHCO Competitors Multiples
Adapthealth Corp Competitors
Adapthealth Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Adapthealth Corp
NASDAQ:AHCO
|
1.3B USD | 0.4 | -18.6 | 5 | 14.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.8B USD | 0.3 | 26.7 | 18.7 | 21 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.1B USD | 0.2 | 42.6 | 14.9 | 18.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD | 0.2 | 31 | 14.9 | 19.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62B CNY | 1.4 | 16.8 | 12.9 | 12.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22 | 10.9 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
